As of Feb 17
| -0.07 / -2.61%|
The 1 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 30.00, with a high estimate of 30.00 and a low estimate of 30.00. The median estimate represents a +1,049.43% increase from the last price of 2.61.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.